[The fibronectin level in patients with rheumatic heart defects undergoing cardiac surgical interventions].
Time course of serum fibronectin is investigated in cardiosurgical patients administered different immunocorrective treatments. The authors propose using fibronectin content as a prognostic criterion in this patient population during the postoperative period.